Product Information
BROMFENAC SODIUM 0.07% EYE DRP is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $12.6625 per ML under NDC 68180043302. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Nov 22, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.805 mg/mL
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180043302
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
BROMFENAC SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206027FDA Approved
11/22/2023
TE Code
AB
On Market Since
1/8/2024
Pharmacological Classes
Price Statistics
The NADAC for BROMFENAC SODIUM 0.07% EYE DRP has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 76.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.6625 per ML |
|---|---|
| All-time high | $75.5251 (Jul 10, 2024) |
| All-time low | $11.7673 (Apr 22, 2026) |
| 52-week high | $15.4792 |
| 52-week low | $11.7673 |
| Median price | $16.1616 |
| Average price | $25.3609 |
| Largest weekly change | -53.9% (Nov 20, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the bromfenac sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BROMFENAC SODIUM 0.07% EYE DRP?
The current National Average Drug Acquisition Cost (NADAC) for BROMFENAC SODIUM 0.07% EYE DRP, manufactured by Lupin Pharmaceuticals Inc., is $12.6625 per ML (NDC 68180043302), effective Aug 19, 2026.
How has the price of BROMFENAC SODIUM 0.07% EYE DRP changed over time?
Over the history we have for it, the NADAC for BROMFENAC SODIUM 0.07% EYE DRP has declined 76.7%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for BROMFENAC SODIUM 0.07% EYE DRP?
Since Apr 17, 2024, the NADAC for BROMFENAC SODIUM 0.07% EYE DRP has ranged from a low of $11.7673 (Apr 22, 2026) to a high of $75.5251 (Jul 10, 2024), with a median of $16.1616 per ML.
Are there cheaper alternatives to BROMFENAC SODIUM 0.07% EYE DRP?
No other NADAC-published product currently shares the active ingredient and strength of BROMFENAC SODIUM 0.07% EYE DRP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BROMFENAC SODIUM 0.07% EYE DRP?
BROMFENAC SODIUM 0.07% EYE DRP (NDC 68180043302) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.